Literature DB >> 618992

Thrombin binding to thrombasthenic platelets.

G C White, E F Workman, R L Lundblad.   

Abstract

Platelets from two patients with Glanzmann's thrombasthenia showed decreased iodination of surface glycoproteins GPIIb and GPIII. Despite these changes, the binding of [125I] alpha-thrombin to the thrombasthenic platelets was normal. Binding was linear up to a thrombin concentration of 0.1 to 0.2 U/ml, at which point a change in the slope of the binding curve was observed. At lower concentrations of thrombin, 1,000 to 2,000 molecules of thrombin were bound per platelet, with an apparent Kdiss of 0.1 to 0.3 U/ml. With high concentrations of thrombin, thrombasthenic platelets bound 30,000 to 65,000 molecules of thrombin per platelet at saturation, with an apparent Kdiss of 5 to 10 U/ml. The release of [14C]serotonin by thrombasthenic platelets as a function of thrombin concentration was also similar to release by normal platelets. These studies indicate that the receptor(s) for thrombin on the plasma membrane of platelets from patients with Glanzmann's disease are intact and that membrane glycoproteins GPIIb and GPIII play little or no role in either the initial binding of thrombin to platelets or the transmission of this surface stimulus to release-inducing mechanisms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618992

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

1.  On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa.

Authors:  K Furihata; D J Nugent; A Bissonette; R H Aster; T J Kunicki
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Identification of the thrombin receptor on human platelets by chemical crosslinking.

Authors:  J Takamatsu; M K Horne; H R Gralnick
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  [The importance of the plasmatic blood clotting system in the early stages of arterial thrombogenesis (author's transl)].

Authors:  H Zaugg
Journal:  Klin Wochenschr       Date:  1979-12-17

4.  Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias.

Authors:  D S Beardsley; J E Spiegel; M M Jacobs; R I Handin; S E Lux
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

5.  Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3.

Authors:  Y Gruel; E Brojer; D J Nugent; T J Kunicki
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.